Program Committee
-
Yomei Matsuoka, MSC, RPH Vice President, Pharmacoepidemiology and PMS Department
Daiichi Sankyo Co., Ltd., Japan -
Satoshi Fukunaga, PHD
UCB Japan Co., Ltd., Japan -
Teruyo Arato, PHD Professor, Clinical Research and Medical Innovation Center
Hokkaido University Hospital, Japan -
Yoshikata Furuya, MSC Manager, General Affairs Division
Sankeien Hoshoukai Foundation, Japan -
Toshiko Ishibashi, PHD, RN Oncology Medical Science Department, Medical Affairs Division
Daiichi Sankyo Co., Ltd., Japan -
Takaaki Ishine Senior Clinical Research Specialist
MSD K.K., Japan -
Kiyohito Nakai, PHD Chief Safety Officer
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Yuko Owada RA Functions Dept.
Novartis Pharma K.K., Japan -
Norikazu Takahata President
Plus Action for Children, Japan -
Nao Tsuchida, MD, PHD Chief
National Hospital Organization Headquarters, Japan -
Yoshiaki Uyama, PHD, MS, RPH Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Have an account?